Kardium Inc. raised $104M in new financing led by Fidelity Management & Research Company, T. Rowe Price Associates, Inc., T. Rowe Price Investment Management, Inc., and Durable Capital Partners LP for innovative atrial fibrillation treatment
Kardium Inc. raised $104M in new financing led by Fidelity Management & Research Company, T. Rowe Price Associates, Inc., T. Rowe Price Investment Management, Inc., and Durable Capital Partners LP for innovative atrial fibrillation treatment
06/11/24, 1:13 PM
Location
vancouverMoney raised
$104
Round Type
pre-seed
Investors
Durable Capital Partners Lp, T. Rowe Price Investment Management, Inc., T. Rowe Price Associates, Inc., Fidelity Management & Research Company
Kardium Inc., developer of the Globe Mapping and Ablation System for the treatment of atrial fibrillation, has raised US $104 million in a new financing round. The round is led by existing investor Fidelity Management & Research Company, together with follow-on participation by funds and accounts advised by T. Rowe Price Associates, Inc. and T
Company Info
Location
vancouver, washington, united states
Additional Info
Kardium Inc. (kardium.com) is a rapidly growing medical solutions company that has developed an advanced system for the treatment of atrial fibrillation: the Globe Mapping and Ablation System. Kardium has built an outstanding team of engineers, medical researchers, compliance and production staff who have worked with top medical advisors to develop the Globe System. Founded in 2007 and headquartered in Vancouver, Canada, Kardium has consistently ranked as one of the top companies to work for in British Columbia.